|
SIPA1L3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.92269999998995E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.30559999992286E-07 |
| Normal-vs-Stage2 |
2.24389999999852E-05 |
| Normal-vs-Stage3 |
6.1886000000011E-05 |
| Normal-vs-Stage4 |
4.613500E-02 |
| Stage1-vs-Stage2 |
4.361400E-01 |
| Stage1-vs-Stage3 |
9.486800E-01 |
| Stage1-vs-Stage4 |
9.863500E-02 |
| Stage2-vs-Stage3 |
5.395400E-01 |
| Stage2-vs-Stage4 |
4.780400E-02 |
| Stage3-vs-Stage4 |
1.279010E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.28189999954098E-07 |
| Normal-vs-AfricanAmerican |
9.347600E-02 |
| Normal-vs-Asian |
4.672000E-01 |
| Caucasian-vs-AfricanAmerican |
2.692100E-02 |
| Caucasian-vs-Asian |
2.978000E-01 |
| AfricanAmerican-vs-Asian |
9.023000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.89450000423975E-08 |
| Normal-vs-Female |
3.976500E-03 |
| Male-vs-Female |
1.962570E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.040200E-03 |
| Normal-vs-Age(41-60Yrs) |
1.78972000000055E-05 |
| Normal-vs-Age(61-80Yrs) |
7.98450000000228E-05 |
| Normal-vs-Age(81-100Yrs) |
3.55320000000603E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.339200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.816000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.710000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.265000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.340100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.867700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.796200E-01 |
| Normal-vs-Grade 2 |
2.31020000018844E-07 |
| Normal-vs-Grade 3 |
3.17400000005019E-06 |
| Normal-vs-Grade 4 |
1.082290E-02 |
| Grade 1-vs-Grade 2 |
3.972000E-04 |
| Grade 1-vs-Grade 3 |
1.299430E-03 |
| Grade 1-vs-Grade 4 |
3.706200E-02 |
| Grade 2-vs-Grade 3 |
6.966200E-01 |
| Grade 2-vs-Grade 4 |
2.273000E-01 |
| Grade 3-vs-Grade 4 |
3.388000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.24090000000565E-07 |
| Normal-vs-ccB subtype |
3.020500E-04 |
| ccA subtype-vs-ccB subtype |
1.209210E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.24850000022315E-08 |
| Normal-vs-N1 |
4.864000E-01 |
| N0-vs-N1 |
3.308100E-02 |
|
|
